DOI:
10.1055/s-00000173
Neuroradiologie Scan
LinksClose Window
References
Fujihara K, Nakashima I.
Secondary progression and innate immunity in NMO: a possible link to alemtuzumab therapy?.
Neurol Neuroimmunol Neuroinflammation 2014;
1: e38
We do not assume any responsibility for the contents of the web pages of other providers.